Alice Lin Pomponio

Alice Lin Pomponio is currently the Managing Director at BrightEdge with a focus on impact venture capital and patient-centric innovation in the fight against cancer. Additionally, Alice Lin holds the position of Vice President Innovation and Impact Investing at the American Cancer Society. With a background in biology and a minor in English Literature from Massachusetts Institute of Technology, Alice Lin also has a Master's in Science & Technology Policy from Harvard University. Alice serves as a Board Observer for multiple healthcare and biotech companies, including TailorMed, NAVERIS, Nusano, Freenome, and more. Alice Lin's expertise in healthcare ventures is further enriched by their participation in the R&D Strategic Leaders Program at Harvard Business School Executive Education.